Advertisement

Topics

Companies Related to "Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes" [Most Relevant Company Matches] RSS

05:55 EDT 21st August 2018 | BioPortfolio

Here are the most relevant search results for "Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes" found in our extensive corporate database of over 50,000 company records.

Showing "Pilot Study Closed Loop Glucose Control People With" Companies 1–25 of 4,500+

Relevant

GlycoMark, Inc.

GlycoMark is an FDA-cleared blood test that reveals repeated episodes of postprandial hyperglycemia/glycemic variability by tracking postprandial glucose levels as they related to blood levels of the molecule 1,5-anhydroglucitol (1,5-AG). Multiple published studies indicate that 1,5-AG detects hyperglycemia not detected by the hemoglobin A1C test. A recent study conducted as part of the internat...


Luminous Medical, Inc.

Luminous is developing an automated blood glucose monitor to address the strong clinical demand for glycemic control. Multiple clinical studies have demonstrated significant morbidity and mortality benefits from controlling glucose levels in critical care patients. As a result, clinicians have rapidly adopted glycemic control procedures but struggle with inadequate and time consuming manual metho...

Integrity Applications, Inc.

Integrity Applications, Inc. is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes. Integrity Applications has developed a non-invasive blood glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with di...


Integ Incorporated

Integ Incorporated is developing the LifeGuide™ System, a next generation hand-held glucose monitoring product for use by people with diabetes that avoids the pain and blood associated with conventional "finger-stick" technologies. Utilizing the Company's proprietary interstitial fluid ("ISF") sampling technology, the LifeGuide(TM) System will allow people with diabetes to frequently self-monito...

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.

LiquiTech

Headquartered in Lombard, Ill., LiquiTech has for more than a quarter century provided water treatment to healthcare, hospitality, commercial, industrial and government facilities, with more than 1,400 installations spanning 10 countries. LiquiTech copper silver ionization employs a highly effective natural biocide that doesn’t have harmful disinfection ...

GlySure Limited

GlySure is leading the way towards improved glycaemic control. As the first to market with a continuous intravascular glucose monitoring system (CIGMS), the Company is enabling critical care physicians to provide improved glycaemic control that has been shown to improve patient outcomes while reducing risk to patients and reducing cost for healthcare provi...

Cardinal Health

Cardinal Health, we understand health care and its unique challenges. When health care leaders called for a better way to safely dispense medications, we were the first to answer with the revolutionary medication automation technology of Pyxis MedStation. Today, Pyxis MedStations safely vend more than 3.8 million medications per day at thousands of health care facilities worldwide. And we don't st...

DreaMed Diabetes

DreaMed Diabetes was established in 2014 to develop and commercialize diabetes treatment and management solutions. Its flagship product, GlucoSitter™, is a closed-loop insulin delivery system for patients with type 1 and type 2 diabetes. Additional development programs include insulin-treatment-profiling systems for diabetic clinics, patient decision-...

Senseonics Holdings Inc.

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics’ first generation continuous glucose monitoring (CGM) system, Eversense®, includes a small sensor, smart transmitter and ...

Pilgrim Quality Solutions

Pilgrim Quality Solutions is a leading global provider of enterprise quality management software and services for the Life Sciences and other highly regulated industries. For more than 20 years, our solutions have automated thousands of processes that ensure the quality of life’s most important products. Product quality and patient safety increase while ...

Nova Biomedical Corporation

Nova Biomedical is a world leader in the development of whole blood analyzers to support the care of home based and hospitalized patients. Based upon innovative biosensor technology, Nova glucose monitors are designed for rapid and accurate measurement of patient glucose levels without coding test strips. Nova Biomedical has pioneered many advances in glucose testing and introduced its first gluc...

Cambridge Technology, Inc.

Cambridge Technology, Inc. was founded in 1978 as a supplier and developer of instrumentation products in the field of biomedical research. At that time we set our standards on technology innovation, high quality manufacturing and customer commitment. In striving to bring the highest levels of precision and accuracy to our products, we laid the foundation for the closed loop galvanometer technolog...

Life Scan Incorporated

For more than two decades, LifeScan has been committed to improving the quality of life for people with diabetes. LifeScan pioneered the modern era of blood glucose monitoring with the introduction of ONE TOUCH® technology. By eliminating wiping and timing procedures, ONE TOUCH Systems helped bring blood glucose testing out of the laboratory and into the hands of patients.

ProNova Solutions, LLC

ProNova Solutions is aggressively developing the next generation of cancer therapy technology in a highly integrated proton therapy medical system. The fusion of state-of-the-art imaging, multi-axis precision positioning, superconducting magnet technology and unprecedented closed-loop treatment verification using PET gives ProNova customers an econo...

Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACC...

DexCom

DexCom, Inc., headquartered in San Diego, California, is a company focused on pioneering technologies for the continuous monitoring of glucose in people with diabetes. DexCom has developed a short term continuous glucose monitoring system, the DexCom™ STS® System which includes the STS Sensor, the STS Transmitter, and the STS Receiver.

Pilot Pharmaceuticals

Pilot Pharmaceuticals develops novel products to treat CNS disorders with unmet medical need and substantial market size. The Company takes candidate drugs from an early discovery stage into clinical development.Pilot Pharmaceuticals will license its products to pharmaceutical companies, allowing them to complete the clinical development, gain regulatory approval and market the product.Pilot Pharm...

Senseonics Holdings, Inc.

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. The Eversense CGM system includes a ...

Monarch Medical Technologies

Monarch Medical Technologies is a privately held medical technology company founded by clinicians with a vision of dramatically improving hospital-based glucose management by replacing traditional “paper and pencil” linear protocols with individualized and predictive computer-based solutions. With the launch of its flagship product, the EndoTool ...

Argose Incorporated

ArgoseTM is a medical research and development company whose principal focus is to develop a completely noninvasive glucose monitor for the detection and monitoring of glucose levels in both children and adults.

Glucon Inc.

Glucon is developing glucose monitoring devices for the diabetes market. Glucon devices will provide continuous, accurate, and real-time glucose monitoring, for clinical and personal use. Glucon devices employ a novel Photoacoustic (optical and sound-based) technology protected by several granted and pending patents. The products will be small, light- weight and conveniently wearable personal devi...

Hacker Group

Founded in 1986, Hacker Group is a digital/direct marketing agency specializing in measurable, ROI-driven sales and marketing programs for blue-chip clients throughout the country including AT&T, Carnival Cruise Lines, Chipotle Mexican Grill, Netflix and others. Using a disciplined approach to strategy development that begins with sales goals to determine ...

SeraCare Life Sciences,Inc.

SeraCare Life Sciences develops, manufactures, and sells a broad range of biological based materials and services essential for the manufacture of diagnostic tests, commercial bioproduction of therapeutic drugs, and additional research applications in the biotechnology, pharmaceutical, and diagnostic industries. SeraCare's offerings include plasma-based therapeutic products, diagnostic products an...

Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly owned subsidiary, Shengtai Holding, Inc. (SHI), and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a manufacturer and distributor in china of glucose and starch products as pharmaceutical raw materials, other starch products and other glucose products such as corn meals, food and beverage glucose and dextrin. For ...


More From BioPortfolio on "Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks